TCA Cycle

Definition

• Tricarboxylic acid (TCA/Krebs/citric acid) cycle: an eight-reaction pathway in the mitochondrial matrix that completely oxidizes the two-carbon acetyl group of acetyl-CoA to CO₂, capturing the released electrons as NADH and FADH₂ plus one GTP by substrate-level phosphorylation.
• Central metabolic hub, not just a furnace: carbohydrate (via pyruvate dehydrogenase), fat (via β-oxidation), and amino acid carbon skeletons all converge on the cycle, and its intermediates are drawn off for gluconeogenesis, heme, neurotransmitter, and nonessential amino acid synthesis.

Why it matters clinically

• It is where oxidative metabolism fails first: because flux depends on reoxidation of NADH by the electron transport chain, anything that blocks the chain (hypoxia, cyanide, sepsis-related mitochondrial dysfunction) or raises the NADH/NAD⁺ ratio (ethanol) stalls the cycle and produces lactic acidosis — the biochemical signature seen on countless exam stems and real ICU gas panels.
• Vitamin-dependent: the cycle and its gatekeeper enzyme are hostage to B-vitamin cofactors, which is why thiamine deficiency is a treatable cause of encephalopathy and high-output heart failure.
• Tumor suppressor biology: germline loss of SDH and FH, and gain-of-function IDH1/IDH2 mutations, turn cycle enzymes into cancer genes — the reason a biochemistry pathway now appears on oncology questions.

Epidemiology worth recalling

• Inherited defects are individually rare but collectively the leading cause of congenital lactic acidosis; PDH complex deficiency (X-linked E1α) is the most frequently identified of these and presents in infancy, disproportionately in males.
• Acquired cofactor deficiency is far more common than any genetic defect: thiamine deficiency clusters in alcohol use disorder, post-bariatric surgery patients, hyperemesis gravidarum, and prolonged unsupplemented parenteral nutrition — populations in which parenteral thiamine is standard, and in whom ASAM alcohol-withdrawal guidance endorses routine repletion.
• Hereditary syndromes: SDHx mutations account for a substantial share of hereditary paraganglioma/pheochromocytoma (NCCN recommends germline testing broadly in these tumors); FH mutations underlie hereditary leiomyomatosis and renal cell carcinoma; IDH mutations define most adult grade 2–3 diffuse gliomas in the WHO CNS classification and occur in a minority of AML.

Entry step (gatekeeper)

• Pyruvate dehydrogenase (PDH) complex: irreversibly decarboxylates pyruvate to acetyl-CoA + CO₂ + NADH, committing carbohydrate carbon to oxidation (this is why fatty acids cannot be made into glucose). Requires five cofactors — thiamine pyrophosphate (B1), lipoic acid, CoA (B5), FAD (B2), NAD⁺ (B3).
• Covalent regulation: PDH kinase (stimulated by ATP, NADH, acetyl-CoA) inactivates it; PDH phosphatase (stimulated by insulin and Ca²⁺) activates it. Fed state and exercising muscle → PDH on; fasting/high fat oxidation → PDH off.

The eight steps and their control points

• Citrate synthase: acetyl-CoA + oxaloacetate → citrate. Flux is set largely by substrate supply; product citrate and NADH inhibit.
• Aconitase: citrate ⇄ isocitrate. Target of fluoroacetate, which is converted to fluorocitrate.
• Isocitrate dehydrogenase: the classic rate-limiting step; first NADH + CO₂. Activated by ADP and Ca²⁺, inhibited by ATP and NADH — the cycle senses the energy charge here.
• α-Ketoglutarate dehydrogenase: mechanistically a twin of PDH (same five cofactors); second NADH + CO₂; inhibited by succinyl-CoA and NADH, activated by Ca²⁺.
• Succinyl-CoA synthetase: thioester energy captured as GTP (substrate-level phosphorylation) — the only ATP-equivalent made without the electron transport chain.
• Succinate dehydrogenase: the only membrane-bound enzyme, identical to Complex II; passes electrons via FAD to coenzyme Q, bypassing Complex I — hence FADH₂ yields fewer ATP. Inhibited by malonate.
• Fumarase: hydrates fumarate to malate.
• Malate dehydrogenase: third NADH, regenerating oxaloacetate. Near-equilibrium, so it is pushed backward whenever the NADH/NAD⁺ ratio rises.

Integration

• Oxygen dependence without using O₂: no step consumes O₂, but the cycle stalls if the chain cannot reoxidize NADH — hypoxia, cyanide, or ethanol all inhibit flux indirectly.
• Ca²⁺ as the contraction signal simultaneously activates PDH phosphatase, isocitrate dehydrogenase, and α-ketoglutarate dehydrogenase, matching ATP output to workload.

Cofactor failures (whole-complex shutdown)

• Thiamine deficiency: PDH and α-ketoglutarate dehydrogenase both stall → pyruvate shunted to lactate. Alcohol use disorder, bariatric surgery, or hyperemesis → Wernicke encephalopathy (confusion, ophthalmoplegia, ataxia), Korsakoff confabulatory amnesia, or wet beriberi (dilated cardiomyopathy, high-output heart failure). Give parenteral thiamine before glucose; a glucose load without thiamine can precipitate Wernicke.
• Arsenic poisoning: binds lipoic acid, inhibiting both keto acid dehydrogenases → lactic acidosis, garlic breath, rice-water diarrhea, QT prolongation, hyperkeratosis; chelation (dimercaprol or succimer) per standard toxicology practice.
• Biotin deficiency: impaired pyruvate carboxylase anaplerosis → fasting hypoglycemia and lactic acidosis, with alopecia and dermatitis.

Inherited enzyme defects

• PDH complex deficiency (E1α, X-linked): neonatal/infantile lactic acidosis with normal-to-high pyruvate, hypotonia, seizures, structural brain malformations. Managed with a ketogenic diet and ketogenic amino acids (leucine, lysine), since ketone bodies bypass PDH entirely.
• Pyruvate carboxylase deficiency: lactic acidosis plus hypoglycemia (gluconeogenesis blocked at oxaloacetate) and neurodegeneration.
• Fumarase deficiency: fumaric aciduria, encephalopathy, severe developmental delay.
• Methylmalonyl-CoA mutase deficiency or B12 deficiency: propionyl-CoA cannot reach succinyl-CoA → methylmalonic acidemia, and in B12 deficiency, elevated methylmalonic acid with subacute combined degeneration.

Oncologic "metabolite" syndromes — the modern high-yield twist

• SDH (Complex II) germline mutations: hereditary paraganglioma–pheochromocytoma; NCCN guidelines recommend germline testing in essentially all patients with paraganglioma/pheochromocytoma, plus SDH-deficient GIST.
• FH (fumarate hydratase) germline mutations: hereditary leiomyomatosis and renal cell carcinoma — cutaneous leiomyomas, early uterine fibroids, aggressive papillary-type RCC.
• IDH1/IDH2 mutations: produce oncometabolite 2-hydroxyglutarate; define IDH-mutant gliomas in the WHO CNS classification and identify AML patients eligible for IDH inhibitors under NCCN guidelines.
• Ethanol excess: high cytosolic and mitochondrial NADH pushes malate dehydrogenase backward → cycle inhibition, lactate accumulation, hypoglycemia, and hepatic steatosis.

• Lactic acidosis + normal or high pyruvate = PDH problem; lactic acidosis + hypoglycemia = pyruvate carboxylase problem. This single split resolves most "infant with acidosis" stems.
• PDH and α-ketoglutarate dehydrogenase share the same five cofactors (thiamine, lipoic acid, CoA, FAD, NAD⁺), which is why one vitamin deficiency or one toxin (arsenic → lipoic acid) knocks out two steps.
• Thiamine before glucose is the single best next step in a malnourished or alcohol-using patient with confusion and ophthalmoplegia — the classic tested sequence.
• Succinate dehydrogenase = Complex II is the only TCA enzyme in the inner membrane and the only one that is simultaneously a cycle enzyme and a chain component; this is why its FADH₂ enters at coenzyme Q and yields ~1.5 ATP.
• Isocitrate dehydrogenase is the rate-limiting enzyme, activated by ADP/Ca²⁺ and inhibited by ATP/NADH — the cycle is governed by energy charge, not by hormone signaling at this step.
• Succinyl-CoA sits at three crossroads: heme synthesis (ALA synthase), odd-chain fatty acid/branched-chain amino acid catabolism via methylmalonyl-CoA (B12-dependent), and ketone body utilization.
• The oncometabolite trio: SDH → paraganglioma/pheochromocytoma, FH → hereditary leiomyomatosis with papillary RCC, IDH1/2 → 2-hydroxyglutarate in glioma and AML. Examiners increasingly link a "TCA enzyme" to a tumor rather than to a metabolic crisis.
• Common distractor to avoid: the TCA cycle consumes no molecular oxygen, yet it is absolutely aerobic — it halts in hypoxia or cyanide poisoning because NAD⁺ cannot be regenerated. Do not choose "O₂ is a direct substrate."
• Second distractor: acetyl-CoA is not an allosteric activator of the TCA cycle itself; it activates pyruvate carboxylase to make oxaloacetate. Also remember it cannot yield net glucose — the two carbons are lost as CO₂.

• 8-step cycle in mitochondrial matrix that oxidizes acetyl-CoA to CO₂, generating 3 NADH, 1 FADH₂, 1 GTP per acetyl-CoA
• Produces ~90% of cellular ATP through oxidative phosphorylation of electron carriers
• Rate-limiting enzymes: isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, pyruvate dehydrogenase (not technically TCA but feeds it)
• Regulated by energy status (inhibited by high NADH/ATP, activated by ADP/AMP)
• Also serves as source of biosynthetic intermediates (anaplerotic reactions)

• Deficiency of cycle enzymes → developmental delay, lactic acidosis, cardiomyopathy, neurodegeneration
• Biotin deficiency (cofactor for pyruvate carboxylase) → impaired anaplerosis, hypoglycemia
• High NADH/NAD+ ratio (e.g., alcohol use) → cycle inhibition, lactate accumulation, hypoglycemia
• Exam question: "How many ATP equivalents from one acetyl-CoA?" → ~10 ATP (3 NADH × 2.5 + 1 FADH₂ × 1.5 + 1 GTP)

• "Citrate Synthase Isocitrate dehydrogenase α-Ketoglutarate dehydrogenase Succinyl-CoA" → "CITRIC ACID CYCLE" (mnemonic for first 4 steps)
• PDH complex deficiency → lactic acidosis, neurological symptoms (X-linked; common in males)
• Fumarase deficiency → fumaric aciduria, neurological disease
• Oxaloacetate replenishment via pyruvate carboxylase (biotin-dependent; activated by acetyl-CoA)
• Succinyl-CoA → heme synthesis (early step critical for RBC production)
• Malate-aspartate shuttle & glycerol-3-phosphate shuttle for NADH transfer into mitochondria

• Forgetting anaplerotic reactions: Students focus only on energy production but miss that ~25% of cycle intermediates are withdrawn daily; pyruvate carboxylase is essential
• Miscounting ATP: Remember FADH₂ = 1.5 ATP (enters at Complex II), not 2 ATP; total ~10 ATP per acetyl-CoA, not 15
• Confusing regulation: High energy (ATP/NADH) inhibits cycle; low energy (ADP/AMP) activates it—counterintuitive for some students

• Supplementation of cofactors (biotin, carnitine, coenzyme Q10 in specific defects)
• Anaplerotic substrates (high-carbohydrate diet, alanine/glutamine supplementation) to replenish intermediates
• Avoid fasting and catabolic states
• Dichloroacetate (experimental) activates PDH in PDH deficiency
• Supportive care for neurological/cardiac symptoms